Literature DB >> 3086830

Effect of dose formulation on isoniazid absorption in two young children.

D A Notterman, M Nardi, J G Saslow.   

Abstract

In an 8-month-old infant with tuberculous meningitis treatment with isoniazid was unsuccessful and was associated with lower than expected plasma concentrations of isoniazid (measured concentration 0.1 microgram/mL). The infant had received isoniazid as a crushed tablet admixed with apple sauce. Oral administration of the parenteral solution of isoniazid (Nydrazid, Squibb) mixed in apple juice produced a higher isoniazid concentration (2.9 micrograms/mL) and the child improved clinically. Pharmacokinetic studies in two subjects were performed following intramuscular injection of isoniazid and oral administration of (1) an isoniazid tablet crushed and mixed with apple sauce, (2) parenteral isoniazid solution mixed with apple juice, and (3) a commercially available syrup containing isoniazid and pyridoxine (P-I-N Forte, Lannett). Of the three oral preparations, the syrup produced the highest peak concentrations (8.3 and 6.9 micrograms/mL). The crushed tablets in apple sauce produced the lowest peak concentrations (1.4 and 2.4 micrograms/mL). Administration of crushed isoniazid tablets with food may be associated with impaired gastrointestinal absorption, lower than expected isoniazid concentrations, and treatment failure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086830

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

Review 1.  A Critical Review of the Current Evidence for Measuring Drug Concentrations of First-Line Agents Used to Treat Tuberculosis in Children.

Authors:  Kyle John Wilby; Sara Shabana; Mary H H Ensom; Fawziah Marra
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

2.  Towards better pediatric drug formulation.

Authors:  B S Karnawat
Journal:  Indian J Pediatr       Date:  1989 May-Jun       Impact factor: 1.967

Review 3.  Educational paper: formulation-related issues in pediatric clinical pharmacology.

Authors:  Catherine Tuleu; Joerg Breitkreutz
Journal:  Eur J Pediatr       Date:  2012-10-31       Impact factor: 3.183

4.  Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing.

Authors:  Wyatt J Roth; Candice B Kissinger; Robyn R McCain; Bruce R Cooper; Jeremy N Marchant-Forde; Rachel C Vreeman; Sophia Hannou; Gregory T Knipp
Journal:  AAPS J       Date:  2013-04-18       Impact factor: 4.009

5.  Off-label drug use among hospitalised children: identifying areas with the highest need for research.

Authors:  Linda Hsien; André Breddemann; Anne-Kristina Frobel; Andreas Heusch; Klaus G Schmidt; Stephanie Läer
Journal:  Pharm World Sci       Date:  2008-01-26

Review 6.  Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research.

Authors:  Helen McIlleron; Susan Abdel-Rahman; Joel Alex Dave; Marc Blockman; Andrew Owen
Journal:  J Infect Dis       Date:  2015-06-15       Impact factor: 5.226

7.  Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.

Authors:  Allen Nalugwa; Fred Nuwaha; Edridah Muheki Tukahebwa; Annette Olsen
Journal:  PLoS Negl Trop Dis       Date:  2015-05-26

8.  Variations in captopril formulations used to treat children with heart failure: a survey in the United kingdom.

Authors:  Hussain Mulla; Magdi Tofeig; Frances Bu'Lock; Nilesh Samani; Hitesh C Pandya
Journal:  Arch Dis Child       Date:  2007-03-15       Impact factor: 3.791

9.  Children's medicines in Tanzania: a national survey of administration practices and preferences.

Authors:  Lisa V Adams; Sienna R Craig; Elia John Mmbaga; Helga Naburi; Timothy Lahey; Cameron T Nutt; Rodrick Kisenge; Gary J Noel; Stephen P Spielberg
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

Review 10.  Improving antibiotic prescribing for children in the resource-poor setting.

Authors:  Kirsty Le Doare; Charlotte I S Barker; Adam Irwin; Mike Sharland
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.